eriocitrin glp-1 Up: What It Is and Why It Works GLP-1 receptor agonists and next-generation
Description
Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled, Obesity and GLP-1 Drugs: A Claims-Based Analysis
Learn what your vials should look like, where to find the prescription label, and how to understand dosage.
What happens if you miss a dose of GLP-1
| 246 comments on LinkedIn
Recent Findings Retatrutide is the first triple agonist (acting on GLP-1/GIP/glucagon receptors) with published phase 2 data in people with obesity as well as in people with T2D
